The patient took 10 mg of distigmine bromide from Distigmine bromide has been widely used for many years in the treatment of voiding difficulties experienced by patients after spinal injuries, prostatectomy, abdominal surgery and gynecological procedures (1-4). The major adverse effect of this drug has been reported to be cholinergic crisis (5). In the present patient, cholinesterase was presented at a low level of 54 IU// (normal range is from 185 to 431 IU//) on admission, and the typical symptoms of cholinergic crisis did not occur. It might be assumed that the rhabdomyolysis had developed under simultaneous intake of colestyramine and pravastatin sodium. However, the patient's CK level did not decrease after discontinuing these drugs but did decrease after discontinuing distigmine bromide. This suggests that the rhabdomyolysis resulted from distigmine bromide. This adverse effect on her muscles might also have been accelera ted by co-administrating colestyramine and pravastatin. When administering distigmine bromide, it is important to carefully check the patient's age and history of taking drugs for anti-hyperlipidemia, especially statins or fibrates. The present case also suggests that rhabdomyolysis is an important complication stemming from treatment with distigmine bromide.
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